orserdu
stemline therapeutics b.v. - elacestrant - bryst neoplasmer - endokrine terapi - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.
copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastiske midler - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.
gavreto
roche registration gmbh - pralsetinib - carcinom, ikke-småcellet lunge - antineoplastiske midler - gavreto is indicated as monotherapy for the treatment of adult patients with rearranged during transfection (ret) fusion-positive advanced non-small cell lung cancer (nsclc) not previously treated with a ret inhibitor.
trimopan 100 mg filmovertrukne tabletter
orion corporation - trimethoprim - filmovertrukne tabletter - 100 mg
trimopan 10 mg/ml oral suspension
orion corporation - trimethoprim - oral suspension - 10 mg/ml
glycopyrronium bromide "martindale" 200 mikrogram/ml injektionsvæske, opløsning
ethypharm - glycopyrroniumbromid - injektionsvæske, opløsning - 200 mikrogram/ml
topiramat "actavis" 100 mg filmovertrukne tabletter
actavis group ptc ehf. - topiramat - filmovertrukne tabletter - 100 mg
topiramat "actavis" 200 mg filmovertrukne tabletter
actavis group ptc ehf. - topiramat - filmovertrukne tabletter - 200 mg
topiramat "actavis" 25 mg filmovertrukne tabletter
actavis group ptc ehf. - topiramat - filmovertrukne tabletter - 25 mg
topiramat "actavis" 50 mg filmovertrukne tabletter
actavis group ptc ehf. - topiramat - filmovertrukne tabletter - 50 mg